key: cord-0869884-u7dapeuu authors: Basiri, Arefeh; Heidari, Arash; Nadi, Melina Farshbaf; Fallahy, Mohammad Taha Pahlevan; Nezamabadi, Sasan Salehi; Sedighi, Mohammadreza; Saghazadeh, Amene; Rezaei, Nima title: Microfluidic devices for detection of RNA viruses date: 2020-08-26 journal: Rev Med Virol DOI: 10.1002/rmv.2154 sha: 6c6a57c1cd9dfac2da6433f156461e2feca6b423 doc_id: 869884 cord_uid: u7dapeuu There is a long way to go before the coronavirus disease 2019 (Covid‐19) outbreak comes under control. qRT‐PCR is currently used for the detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of Covid‐19, but it is expensive, time‐consuming, and not as sensitive as it should be. Finding a rapid, easy‐to‐use, and cheap diagnostic method is necessary to help control the current outbreak. Microfluidic systems provide a platform for many diagnostic tests, including RT‐PCR, RT‐LAMP, nested‐PCR, nucleic acid hybridization, ELISA, fluorescence‐Based Assays, rolling circle amplification, aptamers, sample preparation multiplexer (SPM), Porous Silicon Nanowire Forest, silica sol‐gel coating/bonding, and CRISPR. They promise faster, cheaper, and easy‐to‐use methods with higher sensitivity, so microfluidic devices have a high potential to be an alternative method for the detection of viral RNA. These devices have previously been used to detect RNA viruses such as H1N1, Zika, HAV, HIV, and norovirus, with acceptable results. This paper provides an overview of microfluidic systems as diagnostic methods for RNA viruses with a focus on SARS‐CoV‐2. SARS epidemic would probably break out in the coming years because of the vast reservoir of SARS-like coronaviruses in horseshoe bats and the tradition of eating exotic mammals in southern China. 4 Subsequently, Covid-19 became pandemic. 5, 6 To date, Covid-19 has infected more than 14 million people involving healthcare and non-healthcare settings. 7 It causes a multisystem infectious disorder [8] [9] [10] that is more likely to arise in genetically susceptible individuals 11, 12 and people with pre-existing conditions associated with immune dysregulation. [13] [14] [15] [16] [17] [18] After 7 months of the outbreak and pandemic of 19, 20 no specific treatment and prevention exist, 21 and supportive care is the only option along with anti-inflammatory and antiviral agents. 14, 17, [22] [23] [24] The condition at being the cause of more than 600 000 deaths has promoted international investigative efforts [25] [26] [27] to find tools for earlier diagnosis of Covid-19, allowing us to consider isolation practices as well as apply for supportive care earlier. Early diagnosis of viral diseases can lead to better and more accurate treatment. Cell culture-based techniques are the gold standard for viral detection. 28 Rapid molecular techniques with high sensitivity involve the amplification of viral genomic material and may detect several viruses simultaneously. 28 The two most important types of nucleic acid-based amplification tests (NATs) are nucleic acid sequence-based amplification (NASBA) and real-time polymerase chain reaction (real-time PCR). NASBA is an isothermal and continuous amplification reaction in which three different enzymes are applied: RNase-H, AMV-RT, and T7-RNA polymerase. 29 Real-time PCR involves the amplification of complementary DNA (cDNA) prepared from viral RNA in a real-time manner and is appropriate for the detection of minute amounts of nucleic acids. 30, 31 Another method is a biosensor that has high sensitivity and specificity, and most of the biosensors are based on electrochemical transduction. 32 Covid-19 can be diagnosed in different ways, including CT-Scan and RT-PCR. 33 CT-Scan results indicate bilateral ground-glass and consolidative pulmonary opacities. 34, 35 qRT-PCR is currently used for the detection of SARS-CoV-2, but it is expensive, time-consuming, and not as sensitive as it should be. The shortage of equipment in healthcare centers and the need for better disease management require the development of more convenient and more reliable methods of diagnosis. This review aims to provide an overview of the microfluidic systems as a diagnostic method for RNA viruses with a focus on SARS-CoV-2. The gold standard for the detection of the novel coronavirus is qRT-PCR. 36 However, there may be other methods that allow fast and inexpensive diagnosis. One study used reverse transcription loopmediated isothermal amplification (RT-LAMP) that was conducted in under 30 min. 36 Microfluidic devices might be a rapid diagnostic approach in the future as they are cheap and easy to use. In recent years, such devices have been applied to the diagnosis of several viruses such as influenza, SARS-coronavirus, and smallpox. [37] [38] [39] As a result, these devices may also help detect SARS-CoV-2 and accelerate the process of diagnosis and rehabilitation, ultimately lowering the death rate. These devices can use several techniques such as RT-PCR, RT-LAMP, nested PCR, nucleic acid hybridization, ELISA, or fluorescence-based Assays. [40] [41] [42] [43] [44] 2 | MICROFLUIDIC DEVICES The computer industry has been transformed by microfabricated integrated circuits that significantly reduce the space, effort, and time for computations. Biology and chemistry have the potential to develop through microfluidic systems, which use small amounts of reagent, rapidly 45, 46 . An excellent example of such devices is the home pregnancy test, which detects hormones in urine and is the most commonly used example of the lateral flow strip assays (LFSAs), which are made to detect specific biomolecules. Such devices can also be used for the detection of bacterial cells and cancer cells. 46 Microfluidic devices coated with viruscapturing antibodies can be used to detect viruses present in a solution. 47 Researchers have also developed a microfluidic chip that detects RNAbased viruses from throat swab samples; the H1N1 virus was used as a model for this experiment. 39 Another research developed a microfluidic chip system that can detect SARS-CoV. 38 Generally, there are two different kinds of microfluidic devices; channel-based and paper-based. The paper-based tool is made of a series of hydrophilic cellulose or nitrocellulose fibers that guide liquid in a paper by absorption. The channel-based one could be fabricated using four main methods, including laminate, molding, 3D-printing, and nanofabrication. 48 Channel-based microfluidic devices need channels to create a bed for the integration of reagents. Layers cut separately by using a knife or laser are fused to form the channel. Although it is an easy method, it is impossible to achieve sub-micrometer levels. 49 This is a method of fabricating layer by layer. It has two main parts. One is computer aided design. The second part is a 3D-printer that uses the computer format of stereolithography (STL), building up in 2D layers based on its resolution. 53, 54 There are different methods of 3D-printing, such as fused deposition modeling (FDM), STL and digital micromirror device-based projection printing (DMD-PP), multi-jet modeling, and two-photon polymerization. Although 3D-printing has some limitations, such as the material which can be used 55 and the resolution and biocompatibility of the models, 56 it is a single-step method that does not require the manual working of some other methods such as soft lithography. 57 It will probably become the most common way in laboratories in the future. In the top-down approach, the model size is reduced to the nanoscale until the desired shape and dimensions are achieved. In contrast, the bottom-up approach starts from atomic and molecular levels to finally shape the model. 58 However, NIL, which is a special kind of replica moulding with the resolution of sub 15 nm, is affordable and has many applications in microfluidic fabrication. 60,63 In recent years, portable microfluidic devices have reduced global cost per analysis and reagent consumption and also led to faster analyses due to shorter reactions. 64 RT-PCR can be carried out in two ways: a one-step and two-step. Using the former assay, reverse transcription and PCR occur in a single reaction chamber. The two processes take place in different reaction chambers on the two-step procedure. Colorimetric methods, such as immunochromatographic strips, can be used for RT-PCR product detection in microfluidic chips. 67 Kim et al recently designed a microfluidic-based method for detecting H1N1 influenza, and the results suggested that the limit of detection (LOD) of molecular diagnostics for the virus can be lowered by systematically combining immunomagnetic separation and RT-PCR in one microfluidic device. 40 Moreover, RT-PCR in situ has been successfully used for the diagnosis of Zika virus. 68 Digital microfluidic RT-PCR has been performed in a study to detect Hepatitis A and noroviruses in the gut, and the results showed that absolute quantification by digital RT-PCR may be an appropriate alternative method to standardize quantification of enteric viruses in foodstuffs. 69 Nucleic acid hybridization on a microfluidic chip integrated with the controllable micro-magnetic field has been reported as a rapid method for simultaneously detecting and subtyping multiple influenza viruses. The subtypes H1N1, H3N2, and H9N2 could be simultaneously detected in 80 min with detection limits about 0.21, 0.16, 0.12 nM, respectively. Therefore, this method can be a reliable technology platform with the ability of rapid diagnosis and subtyping of influenza viruses. 43 The enzyme-linked immunosorbent assay (ELISA) is a plate-based assay technique designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. Recently, it has been widely used with microfluidic devices resulting in a fast and affordable method of diagnosing RNA viruses. The commonly used ELISA and fluorescence-based Luminex assay typically consists of three steps and takes several hours to complete, but combining this method with the microfluidic system has led to efficient and rapid diagnosis. Gao LAMP as an alternative process to qRT-PCR that could be performed in less than 30 min, and its specificity was investigated using various types of coronaviruses. Also, the simplicity of the assay allows individuals at home to use it without special equipment. 87 El-Tholoth et al. presented another fast-molecular test with high sensitivity and point-of-care (POC) suitable for home-use. The method is based on LAMP two-stage isothermal amplification (SARS-CoV-2 Penn-RAMP) in closed tubes to create more sensitivity. Finally, detection by fluorescence or colorimetry leads to an easy diagnosis without specific instruments. The sensitivity of RAMP is 10-100 times more than that of LAMP and RT-PCR for SARS-CoV. 88 Nguyen et al. described a POC device, which is rapid, robust, and affordable, with minimal training for emergencies such as the outbreaks. This device uses a LAMP reaction in combination with a lateral flow strip (LFS) to detect the virus in less than 1 h. 89 Another example of using LFS is the BioMedomics COVID-19 IgM/IgG Rapid test. 90 Yang and colleagues designed an RNA-based POC device for the diagnosis of SARS-CoV-2 using both a LAMP assay and a paper-based POC diagnostic device. It was integrated with a smartphone to provide a fast, sensitive, and more accessible tool. This method utilizes a small sample volume, and the fluorescent probe selection can be evaluated by a smartphone to facilitate the recording and sharing of the test results. 91 In conclusion, microfluidic devices offer a wide range of methods, including RT-PCR, RT-LAMP, Nested PCR, Nucleic acid hybridization, ELISA, and Fluorescence-Based Assays, for detection of RNA viruses such as H1N1, H3N2, and H9N2, Hendra, and influenza B viruses. These accurate methods of detecting RNA viruses might also have the potential for detecting the novel coronavirus that has caused a global issue of Covid-19. The authors have no competing interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study. Mohammad Taha Pahlevan Fallahy https://orcid.org/0000-0003- Nima Rezaei https://orcid.org/0000-0002-3836-1827 Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human Hosts and sources of endemic human coronaviruses Advances in Virus Research Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the diamond princess cruise ship: a datadriven analysis Real estimates of mortality following COVID-19 infection COVID-19 affects healthy pediatricians more than pediatric patients Central nervous system involvement in COVID-19 SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences The involvement of the central nervous system in patients with COVID-19 Genetic predisposition models to COVID-19 infection Case report: death due to COVID-19 in three brothers Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health Lymphopenia in COVID-19: therapeutic opportunities SARS-CoV-2-a tough opponent for the immune system Immune-epidemiological parameters of the novel coronavirus -a perspective Challenges for management of immune thrombocytopenia during COVID-19 pandemic The immune system and COVID-19: friend or foe? COVID-19: developing from an outbreak to a pandemic COVID-19: a chimera of two pandemics Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids Regenerative medicine in COVID-19 treatment: real opportunities and range of promises Monoclonal antibody as a potential anti-COVID-19 COVID-19: transmission, prevention, and potential therapeutic opportunities Borderless collaboration is needed for COVID-19-a disease that knows no borders All together to fight COVID-19 The urgent need for integrated science to fight COVID-19 pandemic and beyond Detection of RNA viruses: current technologies and future perspectives Nucleic acid sequence-based amplification Development of real time PCR for detection and quantitation of dengue viruses Detection and monitoring of virus infections by real-time PCR Electrochemical biosensing of mosquito-borne viral disease, dengue: a review The reproductive number of COVID-19 is higher compared to SARS coronavirus Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis Chest CT findings in coronavirus Disease-19 (COVID-19): relationship to duration of infection Rapid detection of novel coronavirus (COVID-19) by reverse transcription-loop-mediated isothermal amplification. The Lancet Real-time PCR assay to detect smallpox virus Determination of SARS-coronavirus by a microfluidic chip system Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics Integrated microfluidic Preconcentration and nucleic amplification system for detection of influenza a virus H1N1 in saliva Paper microchip with a graphene-modified silver nano-composite electrode for electrical sensing of microbial pathogens A nanostructured microfluidic immunoassay platform for highly sensitive infectious pathogen detection Rapid detection and subtyping of multiple influenza viruses on a microfluidic chip integrated with controllable micro-magnetic field Silica bead-based microfluidic device with integrated photodiodes for the rapid capture and detection of rolling circle amplification products in the femtomolar range Microfluidics: fluid physics at the nanoliter scale Microfluidic and paper-based devices for disease detection and diagnostic research Microfluidic device as a new platform for immunofluorescent detection of viruses Fabrication techniques for microfluidic paper-based analytical devices and their applications for biological testing: a review Features in microfluidic paper-based devices made by laser cutting: how small can they be? Micromachines Rapid prototyping of robust and versatile microfluidic components using adhesive transfer tapes Enabling microfluidics: from clean rooms to Makerspaces Encyclopedia of Microfluidics and Nanofluidics Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences 3D printed microfluidics for biological applications Design and additive manufacture for flow chemistry The upcoming 3D-printing revolution in microfluidics Direct, one-step molding of 3D-printed structures for convenient fabrication of truly 3D PDMS microfluidic chips. Microfluid Nanofluid Challenges and breakthroughs in recent research on self-assembly Advances in top-down and bottom-up surface nanofabrication: techniques, applications & future prospects A review of current methods in microfluidic device fabrication and future commercialization prospects. Inventions Perfusable multi-scale channels fabricated by integration of nanoimprint lighography (NIL) and UV lithography (UVL) Facile fabrication of microfluidic systems using electron beam lithography Hybrid nanoimprint-soft lithography with sub-15 nm resolution Fundamentals and Applications of Microfluidics: Artech House Microfluidic platforms for lab-on-a-chip applications An integrated microfluidic chip for DNA/RNA amplification, electrophoresis separation and on-line optical detection Integrated microdevice of reverse transcription-polymerase chain reaction with colorimetric immunochromatographic detection for rapid gene expression analysis of influenza a H1N1 virus A novel microfluidic device integrated with chitosan-modified capillaries for rapid ZIKV detection. Micromachines Digital RT-PCR method for hepatitis a virus and norovirus quantification in soft berries Loop-mediated isothermal amplification of DNA Colorimetric nucleic acid detection on paper microchip using loop mediated isothermal amplification and crystal violet dye Instrumentfree point-of-care molecular detection of Zika virus Microfluidic PCR amplification and MiSeq amplicon sequencing techniques for highthroughput detection and genotyping of human pathogenic RNA viruses in human feces, sewage, and oysters A rapid assay for Hendra virus IgG antibody detection and its titre estimation using magnetic nanoparticles and phycoerythrin Highly sensitive and automated surface enhanced raman scattering-based immunoassay for H5N1 detection with digital microfluidics Wavelengths and lifetimes of paper autofluorescence: a simple substrate screening process to enhance the sensitivity of fluorescence-based assays in paper Integrated microfluidic device using a single universal aptamer to detect multiple types of influenza viruses A novel mutation tolerant padlock probe design for multiplexed detection of hypervariable RNA viruses Selection of high affinity RNA ligands to the bacteriophage R17 coat protein Aptasensors for detection of microbial and viral pathogens Microfluidic platform integrated with graphene-gold nano-composite aptasensor for one-step detection of norovirus Multiplexed efficient on-chip sample preparation and sensitive amplification-free detection of Ebola virus Thermal conductivity in porous silicon nanowire arrays Label-free virus capture and release by a microfluidic device integrated with porous silicon nanowire Forest Sensitive detection of influenza viruses with europium nanoparticles on an epoxy silica sol-gel functionalized polycarbonate-polydimethylsiloxane hybrid microchip Engineering paper-based sensors for Zika virus Rapid Detection of Novel Coronavirus (COVID19) by Reverse Transcription-Loop-Mediated Isothermal Amplification. Available at SSRN 3539654 A single and two-Stage, closed-tube, molecular test for the 2019 Novel Coronavirus (COVID-19) at home, clinic, and points of entry 2019 novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics Point-of-care RNA-based diagnostic device for COVID-19. Point-of-Care RNA-Based Diagnostic Device for COVID-19 Equipment-free nucleic acid extraction and amplification on a simple paper disc for point-of-care diagnosis of rotavirus a High-throughput characterization of HIV-1 reservoir reactivation using a single-cell-indroplet PCR assay Rapid and sensitive detection of viral nucleic acids using silicon microchips Continuousflow, microfluidic, qRT-PCR system for RNA virus detection Simpler, faster, and sensitive Zika virus assay using smartphone detection of loop-mediated isothermal amplification on paper microfluidic chips Digital loopmediated isothermal amplification on a commercial membrane Hands-free smartphone-based diagnostics for simultaneous detection of Zika, Chikungunya, and dengue at point-of-care A wearable microfluidic device for rapid detection of HIV-1 DNA using recombinase polymerase amplification Bandage-like wearable flexible microfluidic recombinase polymerase amplification sensor for the rapid visual detection of nucleic acids Based RNA detection and multiplexed analysis for Ebola virus diagnostics Ultrasensitive immunoassay for detection of citrus tristeza virus in citrus sample using disposable microfluidic electrochemical device Smartphone assisted immunodetection of HIV p24 antigen using reusable, centrifugal microchannel array chip A bead-based immunofluorescence-assay on a microfluidic dielectrophoresis platform for rapid dengue virus detection Label-free detection of influenza viruses using a reduced graphene oxide-based electrochemical immunosensor integrated with a microfluidic platform An inkjet printed, roll-coated digital microfluidic device for inexpensive, miniaturized diagnostic assays A digital microfluidic device with integrated nanostructured microelectrodes for electrochemical immunoassays An impedance aptasensor with microfluidic chips for specific detection of H5N1 avian influenza virus Nanoparticle-enhanced electrical detection of Zika virus on paper microchips Fluorescence biosensor for real-time interaction dynamics of host proteins with HIV-1 capsid tubes Rapid and fully microfluidic Ebola virus detection with CRISPR-Cas13a Microfluidic system for detection of viral RNA in blood using a barcode fluorescence reporter and a photocleavable capture probe An integrated microfluidic system for rapid detection and multiple subtyping of influenza a viruses by using glycan-coated magnetic beads and RT-PCR Microfluidic rapid and autonomous analytical device (microRAAD) to detect HIV from whole blood samples Detection of Zika virus using reverse-transcription LAMP coupled with reverse dot blot analysis in saliva Novel time-resolved fluorescence europium nanoparticle immunoassay for detection of human immunodeficiency virus-1 group O viruses using microplate and microchip platforms Rapid detection of multiple respiratory viruses based on microfluidic isothermal amplification and a realtime colorimetric method Digital rolling circle amplification-based detection of Ebola and other tropical viruses A capillary flow dynamics-based sensing modality for direct environmental pathogen monitoring Rapid, targeted and culture-free viral infectivity assay in drop-based microfluidics Miniaturized devices for point of care molecular detection of HIV Microfluidic devices for detection of RNA viruses